{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T17:32:01Z","timestamp":1790011921328,"version":"4.0.1"},"reference-count":0,"publisher":"American Medical Association (AMA)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Neurol"],"published-print":{"date-parts":[[2016,2,1]]},"DOI":"10.1001\/jamaneurol.2015.3135","type":"journal-article","created":{"date-parts":[[2015,12,14]],"date-time":"2015-12-14T12:31:17Z","timestamp":1450096277000},"page":"203","source":"Crossref","is-referenced-by-count":55,"title":["Combined Plasma and Cerebrospinal Fluid Signature for the Prediction of Midterm Progression From Mild Cognitive Impairment to Alzheimer Disease"],"prefix":"10.1001","volume":"73","author":[{"given":"Benoit","family":"Lehallier","sequence":"first","affiliation":[{"name":"Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Essioux","sequence":"additional","affiliation":[{"name":"Translational Technologies and Bioinformatics, Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann\u2013La Roche, Ltd, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Gayan","sequence":"additional","affiliation":[{"name":"Translational Technologies and Bioinformatics, Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann\u2013La Roche, Ltd, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roxana","family":"Alexandridis","sequence":"additional","affiliation":[{"name":"Translational Technologies and Bioinformatics, Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann\u2013La Roche, Ltd, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tania","family":"Nikolcheva","sequence":"additional","affiliation":[{"name":"Roche Pharma Development, F. Hoffmann\u2013La Roche, Ltd, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony","family":"Wyss-Coray","sequence":"additional","affiliation":[{"name":"Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, California4Center for Tissue Regeneration, Repair and Restoration, Veterans Affairs Palo Alto Health Care System, Palo Alto, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Britschgi","sequence":"additional","affiliation":[{"name":"Neuroscience, Ophthalmology, and Rare Diseases Discovery and Translational Areas, Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann\u2013La Roche, Ltd, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the Alzheimer\u2019s Disease Neuroimaging Initiative","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","container-title":["JAMA Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/jamanetwork.com\/journals\/jamaneurology\/fullarticle\/2474814","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,12,17]],"date-time":"2016-12-17T00:29:04Z","timestamp":1481934544000},"score":1,"resource":{"primary":{"URL":"http:\/\/archneur.jamanetwork.com\/article.aspx?doi=10.1001\/jamaneurol.2015.3135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,1]]},"references-count":0,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaneurol.2015.3135","relation":{},"ISSN":["2168-6149"],"issn-type":[{"value":"2168-6149","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2,1]]}}}